An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia MinorHarika Çelebi1, Celalettin Üstün1, Mutlu Arat1, Hamdi Akan1, Gürol Tunçman2, Tayfun Özçelik2, Tayfun Özçelik2, H. Şenol Coşkun1, Haluk Koç1
1Department Of Hematology And Bone Marrow Transplant Unit, Ibn-i Sina Hospital, Ankara University, Ankara, Turkey
2Department Of Molecular Biology, Bilkent University, Ankara, Turkey
b thalassemia minor is frequent in mediterranean countries. It is a benign disorder and does not warrant any therapeutical intervention. We transplanted a 25-year-old Turkish male who was diagnosed as lymphoblastic lymphoma and had b thalassemia minor as well. He received peripheral blood stem cells transplantation from his HLA-identical sibling who was not a carrier of b thalassemia. After the allogeneic transplantation we did not only observe remission of the lymphoblastic lymphoma but also the disappearance of b thalassemia minor. Keywords: b thalassemia minor, allogeneic peripheral blood stem cell transplantation, lymphoblastic lymphoma
Harika Çelebi, Celalettin Üstün, Mutlu Arat, Hamdi Akan, Gürol Tunçman, Tayfun Özçelik, Tayfun Özçelik, H. Şenol Coşkun, Haluk Koç. An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia Minor. Turk J Hematol. 2000; 17(2): 77-79
Corresponding Author: Harika Çelebi, Türkiye |
|